Talk:Interleukin
From Wikipedia, the free encyclopedia
 |
This article is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at the doctor's mess. | |
| Stub | rated as stub-Class on the assessment scale | |
| ??? | This article has not yet received an importance rating on the assessment scale. | |
 |
This article is within the scope of the Molecular and Cellular Biology WikiProject. To participate, visit the WikiProject for more information. The current monthly improvement drive is Signal transduction. |
||
| Stub | This article has been rated as Stub-Class on the assessment scale. |
||
| Mid | This article is on a subject of Mid-importance within molecular and cellular biology. | ||
|
Article Grading: The article has been rated for quality and/or importance but has no comments yet. If appropriate, please review the article and then leave comments here to identify the strengths and weaknesses of the article and what work it will need. |
|||
[edit] User: Zefito's contribution
User Zefito's contribution was directly from "Fisman EZ, Motro M, Tenenbaum A: Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof. Cardiovasc Diabetol 2003, 12;2:11.", which may be copyrighted.
References are not in Wiki style. --Leeearnest 17:05, 17 March 2007 (UTC)
